Stem Cell Therapy Market in Asia-Pacific to 2018

1
Category Healthcare

• Stem Cell Therapy Market in Asia-Pacific to 2018
  - Commercialization Supported by Favorable
  Government Policies, Strong Pipeline and
  Increased Licensing Activity

2
Synopsis

• GBI Research, the leading business
  intelligence provider, has released its latest
  research Stem Cell Therapy Market in
  Asia-Pacific to 2018 - Commercialization
  Supported by Favorable Government Policies,
  Strong Pipeline and Increased Licensing
  Activity. The report provides an in-depth
  analysis on stem cell research and development in
  India, China, Japan, South-Korea and Singapore.
  The report market analysis and forecasts for
  CABG, LSCT, Type 1 DM, Type 2 DM, Hearticellgram,
  Cerecellgram, Cartistem and Cupistem. The report
  also provides information on trends and
  pipelines. In addition to this, the report covers
  market drivers and challenges for stem cell
  research market.
• Browse Full Report http//www.aarkstore.com/
  healthcare/109512/stem-cell-therapy-market-in-asia
  -pacific-to-2018-commercialization-supported-by-fa
  vorable-government-policies

3
Summary

• GBI Research analysis finds the stem cell
  therapy market was valued at 545m in 2012, and
  is projected to grow at a Compound Annual Growth
  Rate (CAGR) of 10 from 2012 to 2018, to attain a
  value of 972m in 2018. The market is poised for
  significant growth in the forecast period due to
  the anticipated launch of JCR Pharmaceuticals
  JR-031 (2014) in Japan and FCB Pharmicells
  Cerecellgram (CCG) (2015) in South Korea. The
  research is mainly in early stages, with the
  majority of the molecules being in early stages
  of development (Phase I/II and Phase II). Phase
  I/II and Phase II contribute 67 of the pipeline.
  Stem cell research is dominated by
  hospitals/universities/institutions, which
  contribute 63 of the molecules in the pipeline.
  The dominance of institutional research is
  attributable to uncertain therapeutic outcomes in
  stem cell research.The major companies conducting
  research in India include Reliance Life Sciences
  and Stempeutics Research Pvt Ltd, among others.
  The major institutions include PGIMER and AIIMS.

4
Table of contents

• 1.1 List of Tables1.2 List of Figures
  Stem Cell Therapy Market in Asia-Pacific to
  2018 - Introduction Stem Cell Therapy Market
  in Asia-Pacific to 2018 - Overview3.1
  Introduction3.2 Market Characterization and
  Forecasts - Overview3.2.1 Revenue
  Forecasts3.2.2 Cost of Therapy3.2.3 Allogeneic
  and Autologous Share

5
Related Reports

• http//www.aarkstore.com/healthcare/111115/healthc
  are-regulatory-and-reimbursement-landscape-norway
• http//www.aarkstore.com/healthcare/111114/arthosc
  opic-devices-market-by-product-by-end-user
• http//www.aarkstore.com/healthcare/111113/north-a
  merican-joint-reconstruction-market
• http//www.aarkstore.com/healthcare/111111/north-a
  merican-trauma-fixation-devices-market-by-types-by
  -end-users
• http//www.aarkstore.com/healthcare/111108/north-a
  merican-dermatology-treatment-devices-market

6
Stem Cell Therapy Market in Asia-Pacific to
2018 - Commercialization Supported by Favorable
Government Policies, Strong Pipeline and
Increased Licensing Activity

• Published Dec 2012
  112 Pages
• GBI Research, the leading business intelligence
  provider, has released its latest research Stem
  Cell Therapy Market in Asia-Pacific to 2018 -
  Commercialization Supported by Favorable
  Government Policies, Strong Pipeline and
  Increased Licensing Activity
• Price

Format Price
PDF 3500
Site Licence 7000
Enterprise wide Licence 10500
7
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756
4953
You Can Visit http//www.aarkstore.com OR Mail
us at contact_at_aarkstore.com Blog
http//www.aarkstore.com/blog/ Conference
http//conference.aarkstore.com/ News
http//www.aarkstore.com/news